- Home
- » Tags
- » Nucleic acid test
Top View
- COVID-19 Diagnostic Strategies. Part I: Nucleic Acid-Based Technologies
- Verigene® Respiratory Virus Plus Nucleic Acid Test on the Verigene System
- Current HIV Testing Guidelines and Additional Considerations
- The Clinical Effectiveness of Tests to Detect the Presence of SARS-Cov-2 Virus, and Antibodies to SARS-Cov-2, to Inform COVID-19 Diagnosis
- Verigene® Staphylococcus Blood Culture Nucleic Acid Test (BC-S)
- DEC' 5 W2 510(K) Number: K123 197: Verigene® Clostridium Difficile Nucleic Acid Test (CDF)
- Gi Profile Using the Biofire® Platform
- 2018 Guidelines for Use of the HIV Diagnostic Testing Algorithm for Laboratories
- Cobas SARS-Cov-2 & Influenza A/B Nucleic Acid Test for Use on The
- The Main Molecular and Serological Methods for Diagnosing COVID-19: an Overview Based on the Literature
- Nucleic Acid Testing for Diagnosis of HIV in Cases of Negative Or
- Point of Care COVID-19 Testing: Guidance for Practicing Physicians
- Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry
- Testing for Covid-19
- Nucleic Acid Pathogen Testing – (0530)
- Mycoplasma Genitalium Detection in Urogenital Specimens from Symptomatic And
- Nattrol Escherichia Coli 0157:H7
- Current Molecular Methods for the Detection and Quantification
- SARS-Cov-2 Antibody Detection Test Kit Performance Evaluation Protocol
- Nucleic Acid Pathogen Testing
- Moldx: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels CPT: 87631
- Discrepancies Between Antigen and Polymerase Chain Reaction Tests for the Detection of Rotavirus and Norovirus
- Antibody Testing for SARS-Cov-2: Role in Management of the Disease Updated April 8, 2020
- Detection and Differentiation of SARS-Cov-2, Influenza, and Respiratory Syncytial Viruses by CRISPR
- New Generation of Nucleic Acid Testing
- COVID-19 (SARS-COV-2) Nucleic Acid Test, Nasopharyngeal
- Novel Coronavirus 2019-Ncov Nucleic Acid Detection Kit (Real Time PCR) Instructions for Use
- Nucleic Acid Testing to Detect HBV Infection in Blood Donors
- Testing for SARS-Cov-2 in Cellular Components by Routine Nested RT-PCR Followed by DNA Sequencing
- Review Memorandum
- Laboratory Testing for COVID-19 Emergency Response Technical Centre, NIVD Under China CDC March 15Th, 2020 Table of Content
- Molecular Detection of Mycoplasma Genitalium in Endocervical Swabs
- Review of the Cost Effectiveness of Nucleic Acid Test for Transfusion
- New CDC Recommendations for HIV Testing in Laboratories a Step-By-Step Account of the Approach
- HIV Screening Guidelines
- HIV/AIDS Diagnostics Technology Landscape 5 Edition
- COVID-19 Testing Supplies One Year Into the Pandemic Samuel M
- Cobas SARS-Cov-2 & Influenza A/B Nucleic Acid Test
- Verigene® Respiratory Virus Plus Nucleic Acid Test on The
- Is Adding Igm Antibody to Polymerase Chain Reaction Testing Useful for COVID-19 Travel Screening?
- Identification of Microorganisms Using Nucleic Acid Probes
- Testing for Hepatitis C Viral Infections: FREQUENTLY ASKED QUESTIONS
- Testing for HIV and COVID-19: It Is What It Is
- Cobas® Influenza A/B & RSV One Test, Three Viruses, Know for Sure
- Package Insert
- Verigene® Respiratory Virus Plus Nucleic Acid Test on the Verigene
- Snanosphere J.AN10 20 510(K) Summary This 510(K) Summary Is Being Submitted in Accordance with the Requirements of SMDA 1900 and CFR 807.92
- Hepatitis C Testing